Martin D Madaus is of STANDARD BIOTOOLS INC.. Currently has a direct ownership of 104,111 shares of LAB, which is worth approximately $207,180. The most recent transaction as insider was on Oct 20, 2023, when has been sold 1,574 shares (Common Stock) at a price of $2.54 per share, resulting in proceeds of $3,997. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 104K
0% 3M change
1.54% 12M change
Total Value Held $207,180

Martin D Madaus Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 20 2023
BUY
Grant, award, or other acquisition
$3,997 $2.54 p/Share
1,574 Added 1.49%
104,111 Common Stock
Jun 14 2023
BUY
Grant, award, or other acquisition
-
26,376 Added 20.46%
102,537 Common Stock
Feb 20 2023
BUY
Grant, award, or other acquisition
-
29,665 Added 28.03%
76,161 Common Stock
Jun 15 2022
BUY
Grant, award, or other acquisition
-
30,914 Added 39.8%
46,766 Common Stock
Apr 04 2022
BUY
Grant, award, or other acquisition
-
15,852 Added 50.0%
15,852 Common Stock

Also insider at

QTRX
Quanterix Corp Healthcare
RGEN
REPLIGEN CORP Healthcare
AZTA
Azenta, Inc. Healthcare
MDM

Martin D Madaus

Billerica, MA

Track Institutional and Insider Activities on LAB

Follow STANDARD BIOTOOLS INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LAB shares.

Notify only if

Insider Trading

Get notified when an Standard Biotools Inc. insider buys or sells LAB shares.

Notify only if

News

Receive news related to STANDARD BIOTOOLS INC.

Track Activities on LAB